Increasing mortality rates of common malignancies in Colombia: an emerging problem

Cancer
Marion PiñerosF Bray

Abstract

As a result of a major social and demographic transition, Colombia is currently undergoing major changes in disease-specific mortality rates, including an increasing burden of cancer death. The current article described some aspects of the evolution of cancer mortality in Colombia and, in particular, highlighted the trends for the most common causes of cancer death in Colombia. Cancer deaths registered in the national mortality database from 1981-1996 were used to obtain age-standardized mortality rates by gender and site using the world standard population. The estimated annual percentage change was obtained by fitting a simple log-linear model to the rates in the last decade of recorded data, to gauge recent and near-future cancer mortality trends. Between 1987 and 1996, the most common causes of cancer death were gastric carcinoma (17% of all cancer deaths), followed by lung (10.5%), prostate (6.2%), cervical (6%), and colorectal carcinoma (5.4%). There were observed declines in mortality trends noted in both genders for gastric carcinoma. Trends in lung carcinoma appeared to be reaching a plateau among men, but increased among women. There were apparent increases in rates of death from colorectal carcinoma for both genders,...Continue Reading

References

Nov 15, 1987·International Journal of Cancer. Journal International Du Cancer·Y T GaoJ F Fraumeni
Oct 1, 1985·Environmental Health Perspectives·E P Radford
Sep 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L BonneuxP J van der Maas
Oct 19, 1994·Journal of the National Cancer Institute·L H Kuller, R E Schoen
Jul 6, 1994·Journal of the National Cancer Institute·K C ChuL A Ries
Jul 1, 1994·International Journal of Cancer. Journal International Du Cancer·K MagnusT Strand
Nov 1, 1993·Breast Cancer Research and Treatment·P A Newcomb, P M Lantz
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H W NabJ W Coebergh
Jul 7, 1993·Journal of the National Cancer Institute·D G HoelK Mabuchi
Jun 1, 1996·British Journal of Cancer·E FernandezF Parazzini
Aug 1, 1996·American Journal of Epidemiology·K J GoodmanT Collazos Parra
Jul 17, 1998·British Journal of Cancer·A J SwerdlowJ Arrundale
Jul 29, 1998·International Journal of Cancer. Journal International Du Cancer·A W HsingW J Blot
Nov 20, 1998·Cadernos de saúde pública·V L da Costa e Silva, S Koifman
May 21, 1999·The American Journal of Medicine·F GrodsteinM J Stampfer
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P PisaniJ Ferlay
Jun 1, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·E FernandezE Negri
Nov 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviC la Vecchia
Oct 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D M ParkinS S Devesa
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·René LambertHideaki Tsukuma
Jul 18, 2002·Journal of the National Cancer Institute·UNKNOWN International Breast Cancer Study Group (IBCSG)
Jun 5, 2003·Cancer·Phyllis A WingoMichael J Thun

❮ Previous
Next ❯

Citations

Mar 31, 2012·Breast Cancer Research and Treatment·Ana Maria PedrazaAnna Cabanes
May 31, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·A J ZarateF López-Köstner
Nov 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R HanischG I Sánchez
Sep 18, 2010·BMC Health Services Research·Luz Angela Chocontá-PiraquiveFernando De la Hoz-Restrepo
Dec 7, 2007·Internal and Emergency Medicine·M Ponz de LeonP Benatti
Oct 21, 2015·Internal and Emergency Medicine·Stefania MaffeiMaurizio Ponz de Leon
Jun 24, 2006·Environmental and Molecular Mutagenesis·Carlos H Sierra-TorresLeonora Orejuela-Aristizabal
Sep 30, 2016·Cancer Epidemiology·Alejandro Di SibioMónica S Sierra
Sep 30, 2016·Cancer Epidemiology·Monica S SierraDavid Forman
Jan 1, 2008·Breast Care·Raúl MurilloDimelza Osorio
Dec 20, 2016·Biomédica : revista del Instituto Nacional de Salud·Esther De VriesMarion Piñeros
Sep 29, 2006·World Journal of Gastroenterology : WJG·Francia CamposSuminori Akiba
Dec 20, 2016·Biomédica : revista del Instituto Nacional de Salud·Julio Cesar Martínez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
L MinelliF La Rosa
International Journal of Circumpolar Health
Jeppe FriborgMads Melbye
Annals of Oncology : Official Journal of the European Society for Medical Oncology
P Boyle, J Ferlay
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Takanori KobayashiHiroshi Tenjin
© 2021 Meta ULC. All rights reserved